EWA
MRNA icon

Exencial Wealth Advisors’s Moderna MRNA Stock Holding History

Exencial Wealth Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,224
Closed -$311K – 482
2021
Q4 		$311K Buy
1,224
+110
+10% +$32.2K 0.02% 385
2021
Q3 		$429K Buy
+1,114
New +$411K 0.02% 256
2020
Q4 		– Sell
-4,555
Closed -$322K – 393
2020
Q3 		$322K Buy
+4,555
New +$318K 0.02% 299

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Exencial Wealth Advisors's MRNA Position: Q1 2022 in Review

Exencial Wealth Advisors sold out of Moderna (MRNA) in Q1 2022, closing a stake of 1,224 shares — an estimated $311K sold.

Exencial Wealth Advisors first reported a position in MRNA in Q3 2020 and held it in 3 quarters. The position peaked at $429K in Q3 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Exencial Wealth Advisors reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Exencial Wealth Advisors sold 1,224 Moderna shares in Q1 2022, an estimated $311K.
  • Exencial Wealth Advisors first reported a position in Moderna in Q3 2020 and held it in 3 quarters.
  • Exencial Wealth Advisors's Moderna position peaked at $429K in Q3 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Exencial Wealth Advisors's 13F filing for Q1 2022, filed 12 May 2022.